NCT01087125 | Study Connect

Ask a Question

Ask your question and our customer service team will answer it as soon as they can. Questions that do not contain personal information may be posted to our help center to be of service to others

* Required field

Your Email Address *

Please enter a valid email address.

Choose a Topic *

Tell us your question and any additional information *

Please enter all required fields.

Please Log In/Join Now first, and then use this function!

Volunteers across the United States may be eligible to participate.

Recruiting

Abatacept Pregnancy Exposure Registry - IM101-121

Updated: 30 January, 2019 | ClinicalTrials.gov

About This Trial
Key Eligibility Criteria
Trial Site Locations

To participate call
1-877-311-8972

About Study Participation

NOTE: To participate in this study, please call 1-877-311-8972 or visit mothertobaby.org for more information. This observational study does not provide any medication. Data is collected by your local physician. Volunteers across the United States may be eligible to participate.

Print Friendly Summary

CONSIDERING THIS TRIAL?

Print this page and the trial guide to help you talk with your doctor.

Use the Study Participant's Guide to navigate the process of participating in a clinical trial. Understand key factors to consider before deciding and get questions to ask your healthcare team.

Print this page IM101-121

Download Study Participant’s Guide

SELECT LANGUAGE

Trial Details

Gender(s)
N/A

Age Range
1

Location(s)
Recruiting

Treatment Options

Study Arms

ASSIGNED INTERVENTION

Pregnant RA patients with abatacept exposure during pregnancy

Drug: No Interventions

Key Eligibility Criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Currently pregnant women who agree to the conditions and requirements of the study including the interview schedule, release of medical records, and the physical examination of live born infants Exclusion Criteria: - Women who come in first contact with the project after prenatal diagnosis of a fetal abnormality

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -

Call 855-907-3286 or email clinical.trials@bms.com